Vesiculab

Vesiculab operates as a tools and reagents company within the nanotechnology and life sciences sector, specifically targeting the growing field of extracellular vesicle and nanoparticle research. Its core business model involves selling products like Vesi-SEC isolation columns, Vesi-Dye staining probes, Vesi-Safe stabilization buffer, and Vesi-Ref reference materials to academic, biotech, and pharmaceutical research labs. The company supports a wide range of analytical techniques (e.g., NTA, flow cytometry) and aims to accelerate the translation of nanoscale discoveries into clinical applications. While its current description mentions developing exosome-based diagnostics and therapeutics, the website content strongly emphasizes its role as a provider of essential research tools and consumables.

Suite of reagents and consumables for isolation (size-exclusion chromatography), staining, stabilization, and calibration of extracellular vesicles and nanoparticles.

Vesiculab competes in the niche market for EV and nanoparticle research tools. Competitors range from large conglomerates like Thermo Fisher Scientific and Merck (with generic SEC columns and dyes) to specialized startups like HansaBioMed, System Biosciences (SBI), and Izon Science, which offer alternative isolation technologies (e.g., precipitation kits, tunable resistive pulse sensing). Differentiation is based on protocol speed, ease-of-use, and the provision of standardized reference materials.